134 related articles for article (PubMed ID: 26170259)
1. PI3K pathway inhibition in GBM—is there a signal?
Nichol D; Mellinghoff IK
Neuro Oncol; 2015 Sep; 17(9):1183-4. PubMed ID: 26170259
[No Abstract] [Full Text] [Related]
2. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
Ma DJ; Galanis E; Anderson SK; Schiff D; Kaufmann TJ; Peller PJ; Giannini C; Brown PD; Uhm JH; McGraw S; Jaeckle KA; Flynn PJ; Ligon KL; Buckner JC; Sarkaria JN
Neuro Oncol; 2015 Sep; 17(9):1261-9. PubMed ID: 25526733
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of PX-866 in recurrent glioblastoma.
Pitz MW; Eisenhauer EA; MacNeil MV; Thiessen B; Easaw JC; Macdonald DR; Eisenstat DD; Kakumanu AS; Salim M; Chalchal H; Squire J; Tsao MS; Kamel-Reid S; Banerji S; Tu D; Powers J; Hausman DF; Mason WP
Neuro Oncol; 2015 Sep; 17(9):1270-4. PubMed ID: 25605819
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation for GBM in the temozolamide era: in regard to Badiyan et al.
Gondi V; Mehta MP
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):453-4. PubMed ID: 25636772
[No Abstract] [Full Text] [Related]
5. In reply to Gondi and Mehta.
Huang J; Robinson CG; Badiyan SN
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):454-5. PubMed ID: 25636773
[No Abstract] [Full Text] [Related]
6. Radiation as a foundation for glioblastoma therapy in elderly patients. In Regard to Arvold et al.
Giaj Levra N; Fiorentino A; Fersino S; Ricchetti F; Mazzola R; Alongi F
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):217-8. PubMed ID: 26279046
[No Abstract] [Full Text] [Related]
7. In Regard to Arvold et al.
Fiorica F; Colella M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):939. PubMed ID: 26530769
[No Abstract] [Full Text] [Related]
8. In Reply to Levra et al.
Arvold ND; Tanguturi SK; Alexander BM
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):218-9. PubMed ID: 26279047
[No Abstract] [Full Text] [Related]
9. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
10. Treatment options in elderly patients with glioblastoma.
Sharma A; Sharma DN; Julka PK; Rath GK
Lancet Oncol; 2012 Nov; 13(11):e460-1; author reply e461-2. PubMed ID: 23116998
[No Abstract] [Full Text] [Related]
11. Glioblastoma therapy in the elderly: one age does not fit all.
Nghiemphu PL; Cloughesy T
Lancet Oncol; 2012 Sep; 13(9):857-8. PubMed ID: 22877850
[No Abstract] [Full Text] [Related]
12. Prophylactic radiotherapy for glioblastoma in the elderly.
Tartarone A; Ardito R; Romano C
N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
[No Abstract] [Full Text] [Related]
13. [Concomitant radiotherapy with chemotherapy in patients with glioblastoma].
Benouaich-Amiel A; Simon JM; Delattre JY
Bull Cancer; 2005 Dec; 92(12):1065-72. PubMed ID: 16396752
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme--study design and current status report.
Kawabata S; Miyatake S; Hiramatsu R; Hirota Y; Miyata S; Takekita Y; Kuroiwa T; Kirihata M; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2011 Dec; 69(12):1796-9. PubMed ID: 21459588
[TBL] [Abstract][Full Text] [Related]
15. Treatment of brain tumors.
Ashby L; LaRocca R; Ryken T
N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
[No Abstract] [Full Text] [Related]
16. Adjuvant temozolomide: how long and how much?
Franceschi E; Tosoni A; Brandes AA
Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
[No Abstract] [Full Text] [Related]
17. Recent medical management of glioblastoma.
Johnson DR; Chang SM
Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
[TBL] [Abstract][Full Text] [Related]
18. Current therapies for glioblastoma.
Yung WK
Clin Adv Hematol Oncol; 2004 Sep; 2(9):572-3. PubMed ID: 16163238
[No Abstract] [Full Text] [Related]
19. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
Hamilton DA
Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
[No Abstract] [Full Text] [Related]
20. Chemotherapy for brain tumors--a new beginning.
DeAngelis LM
N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
